Gaithersburg, MD, United States of America

William Dall'Acqua

This inventor holds 22 USPTO granted patents and 21 published patent applications and 8 EPO patents. Top assignees: Medimmune Limited, The University of Texas System, Ludwig Institute for Cancer Research Limited. Active years: 2006-2026.

USPTO Granted Patents = 22 (Patent Applications = 21)

% Patents Active = 54.5

EPO Patents = 8 (Patent Applications = 15)

Average Co-Inventor Count = 3.8

ph-index = 13

Forward Citations = 921(Granted Patents)

Company Filing History:

The University of Texas System

patents

1 out of 529

Ludwig Institute for Cancer Research Limited

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715933 - MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES (2026-08-25),

2. 11767369 - Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties (2023-09-26),

3. 10329345 - Stabilized angiopoietin-2 antibodies and uses thereof (2019-06-25),

4. 10011660 - Molecules with reduced effector function and extended half-lives, compositions, and uses thereof (2018-07-03),

5. 9896505 - Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease (2018-02-20),

6. 9562100 - Molecules with extended half-lives, compositions and uses thereof (2017-02-07),

7. 8883992 - Humanized anti-CD19 antibodies (2014-11-11),

8. 8795661 - Molecules with extended half-lives, compositions and uses thereof (2014-08-05),

9. 8775090 - Crystals and structure of a human IgG Fc variant with enhanced FcRn binding (2014-07-08),

10. 8697396 - Modulation of antibody effector function by hinge domain engineering (2014-04-15),

11. 8507656 - Stabilized angiopoietin-2 antibodies and uses thereof (2013-08-13),

12. 8475792 - Molecules with extended half-lives, compositions and uses thereof (2013-07-02),

13. 8323962 - Molecules with extended half-lives, compositions and uses thereof (2012-12-04),

14. 8323653 - Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease (2012-12-04),

15. 8309690 - Integrated approach for generating multidomain protein therapeutics (2012-11-13),

Title: The Innovative Journey of William Dall'Acqua

Introduction: William Dall'Acqua, a talented inventor based in Gaithersburg, MD, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: William Dall'Acqua's most recent patents include a cutting-edge software application designed to streamline data analysis processes in the healthcare industry, as well as a revolutionary device for enhancing renewable energy production efficiency.

Career Highlights: With a career spanning over two decades, William Dall'Acqua has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards, including the prestigious Inventor of the Year accolade.

Collaborations: Throughout his career, William Dall'Acqua has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: William Dall'Acqua's passion for innovation and his relentless drive to push the boundaries of what is possible have cemented his reputation as a pioneering inventor in the technology sector. His contributions continue to inspire the next generation of inventors to think boldly and create solutions that shape the future.